| Home : March 2021 : March 26, 2021 News : European Medicines Agency Accepts Marketing Authorization Application for Enfortumab Vedotin |
European Medicines Agency Accepts Marketing Authorization Application for Enfortumab Vedotin |
March 26, 2021
TOKYO and BOTHELL, Wash., March 26, 2021 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and Seagen Inc. (Nasdaq: SGEN) today announced that a marketing authorization application (MAA) for enfortumab vedotin was accepted by the...
https://www.prnewswire.com:443/news-releases/european-medicines-agency-accepts-marketing-authorization-application-for-enfortumab-vedotin-301256415.html
|
|
|
 Other Stories |
|
|
|
|
|
|
|
|
|
|
|
